Celgene Absorbs Purchase & Data (CELG)

Posted in pre-market 
December 8th, 2009

Celgene Corporation (NASDAQ: CELG) is trading lower this morning, which is also after being lower in after-hours trading.  The stock closed at $55.53 yesterday and at 8:05 AM EST shares are down 3.6% at $53.50 on 124,293 shares of stock so far.  Thyis is after the company is acquiring Gloucester Pharma for its cancer pipeline.  The company’s Revlimid study also slowed disease progression by 50%.

JON OGG

Comments are closed

-->